- Review
- Open access
- Published:
Finding biomarkers of experience in animals
Journal of Animal Science and Biotechnology volume 15, Article number: 28 (2024)
Abstract
At a time when there is a growing public interest in animal welfare, it is critical to have objective means to assess the way that an animal experiences a situation. Objectivity is critical to ensure appropriate animal welfare outcomes. Existing behavioural, physiological, and neurobiological indicators that are used to assess animal welfare can verify the absence of extremely negative outcomes. But welfare is more than an absence of negative outcomes and an appropriate indicator should reflect the full spectrum of experience of an animal, from negative to positive. In this review, we draw from the knowledge of human biomedical science to propose a list of candidate biological markers (biomarkers) that should reflect the experiential state of non-human animals. The proposed biomarkers can be classified on their main function as endocrine, oxidative stress, non-coding molecular, and thermobiological markers. We also discuss practical challenges that must be addressed before any of these biomarkers can become useful to assess the experience of an animal in real-life.
Introduction
The welfare of animals has been a concern to some segments of society for centuries [1, 2]. In Western societies, debate about animal welfare moved toward center stage from the middle of the last century and has continued to do so, while the issue became globally widespread in the 2000’s [3]. During these decades of debate, a recurrent premise has been that non-human animals (hereafter “animals”) experience the events in their life in a similar way to humans, and therefore people should treat animals with care and have respect for their welfare [1]. Along with the growing societal demand for better welfare for animals, a scientific approach to better understand and assess animal welfare has emerged. Progress in animal welfare science has laid the foundation for several frameworks that can be used to assess the welfare of animals that are under human care [1]. The nature of the experience that an animal has is central in all of these frameworks with diverse levels of importance [4]. Several behavioural and physiological indicators have been developed that are informative in the assessment of welfare [4]. For example, motor activity and body posture, cortisol, and heart rate can change in animals in response to a life event. Animal biologists have shown that these behavioural and physiological changes are controlled via modulation of the autonomic nervous system and the hypothalamic–pituitary–adrenal (HPA) axis [4]. While they are useful to assess the response of an animal to an experience, these indicators provide little information on the experiential process itself. In this review, we propose several biomarkers that may better reflect the experience of an animal during its lifetime. While most of the biomarkers that we identify are suitable primarily for mammals, further research may support their utility in other taxa. First, we briefly illustrate the use and limitations of existing indicators to assess animal experience. We then discuss several proposed biomarkers from the human biomedical sciences by outlining their relevance and their limitations to assess animal experience. After reflecting on the inherent difficulties of the validation of biomarkers of experience in animals, we offer some strategies to circumvent these difficulties. In conclusion, we describe the necessary features that a meaningful biomarker, or system of biomarkers, would require to estimate the experiential state of an animal.
Where are we now?
At present, animal-based indicators can be divided into behavioural, physiological, and neurobiological indicators. They all provide valuable information on the mental state of an animal. The next section reviews biomarkers that are used currently and stresses how closely they are related to the experiential state. We deliberately focus mainly on the limitations that have been identified for each biomarker to demonstrate the potential gaps that new biomarkers could fill. The reader is encouraged to consult the cited references to appreciate the extent and the usefulness of the previous 60 years of work in this field in assessing animal welfare. We could not possibly cover that entire history in the present review.
Behavioural indicators
Behavioural observation and several behavioural tests have been used extensively in the assessment of animal welfare [4]. Behavioural indicators are non-invasive, can be used on individual animals within groups, and are adaptable to many settings. Despite their practicality, the major limitations of behavioural indicators in the assessment of animal welfare are that they are either non-specific or too species-specific, affected by individual differences, and can be influenced by past and learned experiences (Table 1). Behaviours can be used as indicators of the experiential state of an animal on the assumption that certain behaviours are more likely to occur when an animal is in a positive or negative mental state [5]. However, behavioural changes are often indicative only of an extreme welfare state and mainly associated with a negative welfare state [6, 7]. Importantly, the behavioural indicators that are associated with a positive welfare are not very discriminative because they are usually essential behaviours, such as feeding and maternal behaviours [8, 9]. While behaviour can provide valuable information on how an animal is responding and coping in its environment, it does not necessarily provide insight into the experiential state of an animal.
Physiological indicators
Physiological indicators of animal welfare (Table 2) have focused on the assessment of biological functioning rather than the experiential state of an animal [48,49,50]. The interpretation of any change in a physiological marker can be challenging because most physiological indicators respond to both positive and negative stimuli [51]. Variation in the method of measurement of a physiological response can hinder interpretation when samples derive from different sources, such as blood, saliva, hair, or feces [52]. The concentration of a hormone in different types of samples are not always correlated due to differences in time between synthesis, secretion, transport, metabolism, and action [48,49,50]. Moreover, it is difficult to establish the point where a physiological indicator reflects an adaptive response to a life event from the point where it reflects that an animal is no longer coping with that life event. Importantly, physiological indicators can reflect negative or neutral welfare states, but rarely a positive welfare state, which is a major limitation when trying to understand the full spectrum of experiential states of an animal.
Neurobiological indicators
There have been several attempts to develop neurobiological indicators to assess animal welfare. Measuring the activity of systems of neural circuity and neurochemical reactions could offer a unique insight into the processes that are occurring in the brain of an animal [86,87,88]. As with behavioural and physiological indicators, neurobiological indicators have targeted mostly the negative experiential state, such as pain, fear, and stress, and to a lesser extent the circuits that are known to be associated with positive experience, such as anticipation and reward [29]. The activity of the neural circuits has been assessed by measuring specific neurochemicals (e.g., dopamine, serotonin, and endogenous opioids) in cerebrospinal fluid or neural tissue [89]. Neurochemical indicators are very valuable as they interrogate the communication networks with the brain, but they are not practical because the sampling techniques are invasive (e.g., to access cerebral spinal fluid or neural tissue) and the markers are often measured at a single time point. There are less invasive techniques that can be used to localize and measure the neurochemical and electrical activity of the brain, including neuroimaging techniques, such as functional magnetic resonance imaging, functional near infrared spectroscopy, and electroencephalography [90, 91], but these techniques also have limitations. While electroencephalography can measure brain activity in real time, the technique is not easily used in environments where most animals live, such as paddocks on a farm, and it cannot be used to assess many animals simultaneously. Beyond the research setting, the available neuroimaging techniques are impractical because they require specialized equipment and an animal needs to be restrained and sedated or anesthetized to be assessed, which can influence the results. Similarly, the available neurobiological indicators require extensive validation to become markers of the experiential state of an animal because levels of a mediator can be involved in different brain pathways and their activities are context dependent. For example, dopaminergic pathways are involved in several functions including pain, cognition, and personality, and can be modulated by several endogenous factors including oxidative stress [92, 93].
In the above sections, we have briefly argued that the available behavioural and physiological biomarkers, while informative, are proxies for the brain mechanisms that generate the experiential state. Neurobiological markers are a step closer to the neuronal activation that is linked to experience, but they are either too generic or impossible to measure in real-time or during real-life events. As pointed out in the introduction, an experiential state results from brain processes, so it seems obligatory to direct the search for relevant indicators using knowledge from the field of neuroscience [4].
Where to go?
Concepts and methodologies from human neuroscience may offer some understanding of the experiential state of an animal [88]. In the following sections, we will discuss several candidate biomarkers (Fig. 1) by providing a short description of their biology and then a concise review of their association with either mental experience or mental dysfunction in humans. The selected biomarkers are either markers of cellular function or markers involved in the control of gene expression. The candidate biomarkers have been shortlisted based on their localization in areas of the brain that are involved in emotion, personality, and cognition and their involvement in psychiatric disorders such as mood and personality disorders, schizophrenia, anxiety, and stress-related disorders using first the literature in humans and additional information from animal models [89, 94]. We will briefly discuss the media in which the biomarkers can be found and the methods of detection. The list of proposed biomarkers is categorized according to the main function of each biomarker and comprises of endocrine, oxidative stress, non-coding molecular, and thermobiological markers.
Endocrine makers
Each of the endocrine markers that is discussed below can be part of a complex control system and can affect downstream signals and/or effectors. We have chosen to target the main endocrine signals because the downstream effectors are often, if not always, under the influence of other endocrine or non-endocrine systems which might not react to the experiential state.
Oxytocin
Oxytocin is a nonapeptide hormone that is produced in the supraoptic and paraventricular nuclei of the hypothalamus. It is released by the posterior pituitary into the bloodstream from where it perfuses the body [95], and in the central nervous system (e.g., ventral tegmental area, frontal cortex, and brainstem) [96]. Oxytocin is known for its role in the contraction of smooth muscle that is associated with parturition and milk let-down, and its role in stimulating maternal behaviours in humans and other mammals [97]. Oxytocin receptors are found in several regions of the brain that are involved in the control of maternal behaviour, including the medial preoptic area, ventral tegmental area, and nucleus accumbens [97]. In humans, similar to other mammalian species, the cell bodies of neurons with oxytocin receptors are found in cortical regions and limbic structures, but not in the hippocampus [96]. A role for oxytocin in mood and personality disorders, schizophrenia, and autism has been established via studies that have investigated the plasma and CSF levels of oxytocin, mutations in the genes for oxytocin or oxytocin receptors, and responses to the administration of oxytocin [98]. Interestingly, in humans, comfortable physical contact increases the endogenous secretion of oxytocin [99]. Oxytocin has an apparent role during the expression of anxiety and stress because levels increase in those situations, but it might act as a circuit-breaker rather than as a direct correlate of the negative affective state. There is an interaction with the HPA axis [100, 101]. In response to an acute or a chronic psychological stressor, cortisol and oxytocin both increase in blood and saliva, but following that initial co-activation, during the recovery period indicated by changes in other stress makers, such as heart rate variability, oxytocin seems to have an anxiolytic effect and is associated with a reduction of cortisol synthesis [102,103,104]. Altogether, structural and functional studies in humans support a role for oxytocin in attenuating negative experiences such as anxiety and stress, as well as in eliciting positive experiences.
The intranasal or intracerebral administration of oxytocin attenuates the increase in cortisol concentration that occurs in response to various stressors, including social isolation, in humans and other animals [105, 106]. So, oxytocin seems to be related to positive life events. The serum concentration of oxytocin is correlated with positive social behaviours in cattle, rats, and primates, while there is no correlation between oxytocin and antagonistic behaviours [107]. The apparently anomalous involvement of oxytocin with the HPA axis could be an indication that oxytocin provides a measure of the stress resilience or coping capacity of an animal, rather than being a direct correlate of the stressor itself [101, 107,108,109].
Despite the apparent role of oxytocin in positive experience, validation is still necessary before oxytocin can be used as a reliable biomarker of the experiential state of an animal. It would be important to demonstrate a strong correlation between levels obtained centrally, in cerebrospinal fluid or by microdialysis in neural tissue, and peripherally in the blood (serum and plasma), urine, or saliva samples [95, 107, 109]. There may be some delay between the response observed centrally and levels in peripheral samples [109].
Growth hormone (GH), insulin-like growth factor one (IGF-1), and insulin-like growth factor binding proteins (IGFBPs)
Insulin-like growth factor one (IGF-1) is under the control of growth hormone (GH) and regulates growth and metabolism in the body [110]. To a large extent, the circulating levels of GH and IGF-1 depend on nutrient intake as well as the action of hormones that act on the hypothalamus, such as cortisol [111]. IGF-1 is produced in the liver, muscle, and fat and crosses the blood–brain barrier by active transport where it can impact on several brain functions, and is expressed in neurons and glial cells [110]. The paracrine and endocrine actions of IGF-1 in the central nervous system are modulated by insulin-like growth factor binding proteins (IGFBPs) which are also expressed in neurons and astrocytes [112].
IGF-1 is involved in general cellular growth, neural development, and neural protective mechanisms in the brain [110]. Dysregulation of the IGF-1 system has been associated with neurodegenerative diseases, such as Alzheimer’s, Parkinson’s, and Huntington’s disease [112]. In Parkinson’s disease, lower circulating levels of IGF-1 are associated with poor cognition [113], poor mood, and high anxiety [114]. Mice with knockout of both the insulin receptor and the IGF-1 receptor in the hippocampus and central amygdala present with anxiety-like disorders and impaired cognition, demonstrating that the IGF-1 signaling is involved in cognition and personality [115].
The GH/IGF-1 axis is affected by acute and chronic exposure to stressors. The expression of IGF-1 and IGFBPs is lower after exposure to stress, and both IGF-1 and IGFBPs respond dynamically to glucocorticoids, which could result in changes in cellular and neural functioning [110, 116, 117]. Overall, changes in the circulating levels of IGF-1 and possibly IGFBPs, could be correlated with changes in the experiential state in response to internal and external events [118]. Although their utility in that respect might be limited because they are secreted in pulsatile patterns and, as described above, they have complex interactions.
Brain-derived neurotrophic factor (BDNF)
Brain-derived neurotrophic factor (BDNF) is a very well-studied neurotrophin. BDNF plays an important role in the development and maintenance of brain function by mediating neuron survival and function. BDNF mRNA expression and BDNF immunoreactivity have been measured in the cortex, hippocampus, and amygdala of humans and rodents (for review see [119]). In humans, there is evidence for a role of BDNF in the pathophysiology of brain-associated illnesses. Patients with depression have lower expression of BDNF in brain tissue and lower levels in peripheral blood. Treatment of those patients with antidepressants can normalize those levels [120]. While the serum concentrations of BDNF are lower than normal in female patients with generalized anxiety disorder, the levels are not strongly related to anxiety disorders in general [120].
Similarly, in rodents, low levels of serum BDNF have been correlated with emotional and depressive-like behaviours [121, 122], and the level decreases following acute and chronic stress [123]. Like in humans, the administration of antidepressants increases the level of BDNF in the rat brain and the administration of BDNF into the hippocampus of rats produces antidepressant effects [124, 125]. BDNF, possibly by acting on synaptic plasticity, has been proposed to have a fundamental role in mediating changes in the central nervous system that are induced by experience and behavioural learning (for review see [126]). In rats, increases in the expression of BDNF mRNA and levels of BDNF in the medial forebrain, cerebral cortex, hippocampal formation, and hindbrain are associated with more play behaviour, improved spatial learning, and increased exploratory behaviour following environmental enrichment [127,128,129,130]. Importantly, increases in the level of BDNF mRNA in the hippocampus in response to a spatial memory test (Morris water maze) was not observed when rats were kept either in isolation or in a poor environment, suggesting that life situations that are perceived positive, such as enrichment or social contact, impact central BDNF [127,128,129]. Overall, evidence in humans and animal models suggests that the central expression of BDNF and potentially serum concentrations could be a biomarker of both the positive and the negative experiential state.
While the level of BDNF can be measured both centrally and peripherally, the usefulness of peripheral measures to assess the experiential state remains to be demonstrated. In pigs and rats, there was a moderate correlation between plasma and whole blood concentrations of BDNF and hippocampal BDNF (r2 = 0.41 to 0.44; [131]). Other studies have found no correlation between the peripheral and central level of BDNF, and to complicate matters further, the concentration of BDNF in saliva does not always reflect the concentration of BDNF in plasma [131,132,133,134]. The lack of correlation between the central and peripheral concentration of BDNF could be due to any of the multiple factors that are known to affect BDNF production such as sex, energy status and, as described above, the impact of life experiences. In addition to its expression in neural tissue, BDNF is produced centrally and peripherally in nonneuronal tissues [120], and at least in humans, the storage of BDNF in platelets contributes to up to a 200-fold difference between the concentration of BDNF in serum and plasma [135]. Importantly, different isoforms of BDNF have different biological functions, at least during neurodevelopment, that are influenced by serotonin [136]. The development of BDNF as a reliable marker of the experiential state will require demonstration of the biological relevance of the isoforms of BDNF and will also need to validate the type of sample, sampling technique, processing of samples, and storage that are all known to affect the peripheral concentration of BDNF [137, 138].
Orexins
Orexins, also known as hypocretins, are neuropeptides that are produced centrally [139]. The two orexins, orexin-A and orexin-B (also known as hypocretin-1 and hypocretin-2) are produced in neurons of the lateral hypothalamus, perifornical area, and dorsomedial hypothalamus [139]. Orexinergic neurons project throughout the central nervous system including the prefrontal cortex and other areas of the cortex and the amygdala [140].
Orexins play an important role in energy homeostasis, sleep, arousal, and reward processing [139]. In humans, lower concentration of orexins in either CSF or serum has been associated with a deficit in cognition and a higher incidence of neurodegenerative diseases such as Alzheimer’s, Huntington’s, and Parkinson’s disease [141]. A role for orexin in emotion and cognition has been suggested by studies that have applied one of the few antagonists and agonists of orexins [142]. In rodent models, orexins are involved in the modulation of mood, motivation, reward, and stress responses [143,144,145]. The central administration of orexins has an anti-depressant effect in mice and rats and thus supports a role for orexin in the modulation of mood and the coping capacity of an animal [146, 147]. In addition, the orexinergic pathways modulate several networks of neurotransmitters, including those that use dopamine, serotonin, and GABA, which are all involved in mental states including positive and negative emotions [142]. Recently, the reliability of the immunoassays that are used to measure orexins in serum, plasma, and CSF have been questioned, meaning that the established relationship between central and peripheral orexins will need to be validated with new analytics before they can be considered as a biomarker of experience in animals [148, 149].
Endocannabinoids
The endocannabinoid system includes the endocannabinoids, the enzyme that degrades them, and the endocannabinoid receptors [150]. Endocannabinoids are lipid-derived neurotransmitters, the most studied being N-arachidonylethanolamine (AEA) and 2-arachidonoylglycerol (2-AG). Both are synthesized in the peripheral and the central nervous system [151]. At the brain level, the endocannabinoids act via the cannabinoid receptor subtype 1 (CBR1) and those receptors are located mainly in regions of the brain involved in emotional behaviour, such as the prefrontal cortex in rodents [150]. The CBR1 receptor is expressed in GABAergic, dopaminergic, glutaminergic, and serotoninergic neurons in the medial prefrontal cortex [150]. Because the CBR1 receptor can be found in the neuron body, the axon, and the dendrites, the activity of the receptor can modulate the activity of those other neurotransmitters in several ways [150]. The endocannabinoid system has been implicated in the neuromodulation of several physiological systems, including pain [152], the stress response [153], anxiety [154], cognitive processing, and general homeostasis [155]. Interestingly, acute exposure to a stressor reduces the level of AEA in the synaptic space of neurons by increasing the activity of the enzyme that degrades AEA (i.e., fatty acid amide hydrolase) [153]. The endocannabinoid system is affected by stress and modulates the stress response [153].
A higher concentration of circulating endocannabinoids has been associated with reduced anxiety, less depressive behaviours, and elevated mood [156]. In rodents, studies using either antagonists of CBR1, CBR1 knockouts, or injection of endocannabinoids have demonstrated that the endocannabinoid pathway is involved in the behavioural expression of emotions, such as anxiety-like behaviours, during an elevated maze test [150]. While endocannabinoids have been measured in plasma and serum, they can also be measured in saliva, urine, milk, and hair [156]. In ruminants, the endocannabinoid system has been studied for its role in the control of reproduction [157,158,159], lipid metabolism and food intake [160], and the immune system [160]. However, to date no study has investigated the role of endocannabinoids in brain processes that are related to emotion reactivity. All of the data above suggests that endocannabinoids could be markers of the positive experiential state in animals, most probably linked to food intake and resilience to stress. The study of such associations will require well designed experiments because food intake can affect the level of circulating endocannabinoids by changing the activity of the microbiome [161].
Markers of oxidative stress
Oxidative stress occurs when the homeostasis of oxidation–reduction activity is no longer maintained. A redox imbalance can be triggered by challenges that increase the production of reactive oxygen species (ROS) and reactive nitrogen species (RONS) and non-radical reactive derivatives (oxidants), or decrease the intake or synthesis of antioxidants, or increase the antioxidant turnover [162, 163]. Several types of challenge have been associated with an increase in oxidative stress including sepsis, mastitis, enteritis, pneumonia, metabolic disorders, and neurodegenerative disease [164]. The central nervous system is particularly sensitive to oxidative stress because of the high consumption of oxygen by neurons, the susceptibility of the lipid membrane of neurons to RONS, and the relative paucity of enzymes that reduce RONS [165]. RONS have been implicated in the neuronal death that is associated with the development of neurogenerative diseases, such as Parkinson’s and Alzheimer’s disease [166]. Interestingly, oxidative stress seems to interact with both IGF-1 and BDNF in the cognitive decline that is linked to neurodegeneration [166, 167]. In additional studies, 8-hydroxy-2-deoxyguanosine a marker of oxidative DNA damage, is used as a marker of cellular stress and supports a link between oxidative stress and depression. People with clinical depression have higher serum concentrations of 8-hydroxy-2-deoxyguanosine than controls [168, 169]. Long-term yoga practice had a positive impact on the mood state in people with clinical depression, but only tended to decrease levels of 8-hydroxy-2-deoxyguanosine in the urine [169]. The impact of oxidative stress on neurogenerative diseases seems to be related to a long-term imbalance in redox, suggesting that markers of oxidative stress could be useful indicators of long-term changes, rather than short-term changes, in the experiential state.
External environmental factors play a significant role in the prevention and mitigation of oxidative stress, mainly by increasing the level of antioxidants. In humans, nutritional antioxidants reduce the impact of neurogenerative and cognitive disorders [166]. In animals, in addition to dietary supplementation, the antioxidant status can be improved when environmental conditions induce a positive experiential state. Such environments include pasture-based systems for cattle, enriched housing systems for piglets, and protection from the cold for lambs [170,171,172]. Whether environmental enrichment causes the production of fewer oxidants, or improves antioxidant protection, remains unknown. Because of that association, the level of oxidative stress could serve to evaluate the positive experiential state of an animal. That could be achieved by assessing the redox balance by measuring reactive species and antioxidants [162, 164, 173].
The assessment of redox balance can be complicated because of the large number of biomarkers that are used to assess oxidative stress and antioxidants, their sensitivity to any metabolic change, and limitations of the detection technique [174]. Glutathione is a low molecular weight thiol-containing compound that is produced in the brain and has a neuroprotective role against oxidative stress via its role as a critical antioxidant [175]. Low levels of glutathione, centrally and peripherally, are indicative of oxidative stress, and those low levels correlate well with the severity of several neurodegenerative diseases and cognitive impairment [176]. Because thiol-redox homeostasis can have a significant role in neurodegenerative disease [175], the measurement of thiol-oxidation in biological media could be used to assess the experiential state. It is possible to measure the oxidation of cysteine in plasma albumin using the oximetric method [177]. The oximetric detection of thiol oxidation requires only a drop of blood and is highly sensitive. Measures of thiol oxidation are sensitive enough to detect changes in oxidative stress in response to exercise and muscle damage in humans and in response to a change in water quality in fish [178, 179]. The oximetric method, however, has not been validated in other species as a method of assessing oxidative stress.
Non-coding molecular markers
Non-coding molecular markers, such as long noncoding RNAs (lncRNAs) and microRNAs (miRNAs), are found in many tissues including the brain. Non-coding RNAs can influence all types of cellular activity, from the general activity of neurons to complete cell apoptosis. LncRNAs and miRNAs could be relevant biomarkers of the experiential state since both have been linked to neuronal activity, neurodegenerative disease, and in some cases, associated with deficits in cognition [180].
In this section we discuss the potential of miRNAs, and one lncRNA, as biomarkers of experience. The lncRNA, the nuclear paraspeckle assembly transcript 1 (NEAT1), appears very promising as a biomarker of experience. GlycoRNAs, a modified RNA, will also be considered very briefly. Aside from the RNA-based biomarkers, we will also discuss the relevance of telomere length, since the attrition of telomeres has been linked to neurogenerative disease and cognitive decline [181, 182].
Micro-ribonucleic acid (miRNA)
MicroRNAs (miRNAs) are small noncoding RNAs (19–23 nucleotides) that influence gene expression by interacting with messenger RNAs (i.e., coding RNAs) [183]. MiRNAs play an important role in physiological and psychological functioning at a cellular and genetic level in higher organisms. MiRNAs, and other non-coding RNAs, also play a role in epigenetic changes that impact on gene expression and can be inherited, at least in the case of paternal stress (for review see [184]). In humans and other animals, the expression of miRNAs in the brain changes in response to changes in the external environment, such as sensory changes and dietary modifications, and has been associated with experiential states such as stress, depression and anxiety, and brain processes such as reward and decision making [183].
Negative mental states and psychological disorders have been associated with changes in miRNAs in brain tissue [185]. Changes in several miRNAs in the amygdala have been observed in mice that display anxiety- and depressive-like behaviours, as well as in mice that experience chronic social defeat [186, 187]. Acute and chronic stress causes alterations in the level of miRNAs in areas of the brain that are important in behaviour, emotion, and cognition [183]. In addition, changes in specific miRNAs are observed after the administration of antidepressant drugs (miR-16; [188]). MiRNAs have been implicated in the modulation of serotonergic (miR-135 and miR-16; [186, 189]) and dopaminergic reward pathways (miR-504; [189]).
In humans, circulating miRNAs have been proposed as informative biomarkers for mood disorders and as predictors of suicidal behaviour (for review see [190]). In rodents, miRNAs in the brain have been associated with human-like psychological disorders, but such associations have not been extensively studied in larger animals. Consequently, there is little information on the identification and annotation of miRNAs between humans and laboratory rodents, and other larger animals such as farm animals. The reference database for microRNA (release 22.1, accessed 16 July 2023, https://www.mirbase.org/) contains 2,654 mature miRNAs for humans, 1,998 for mice, but only has 1,025 mature miRNAs for cattle, 457 for pigs, and 10 for sheep [191]. It is unlikely that those numbers reflect differences in the biology of the species, but rather reflect the intensity of study. In addition, in farm animals, studies of miRNAs have focused mainly on miRNAs associated with production traits such as meat quality [192]. While miRNAs have been proposed to be potential biomarkers of animal welfare and health in livestock and poultry [193], most efforts toward the identification of specific miRNAs have focused on the ability of the animal to cope with external challenges and the associated stress response rather than experience [183].
Although the identification of miRNA biomarkers that might be associated with the experiential state of an animal remains a work in progress, the miRNAs offer a very promising avenue. Their measurement could be practical and highly specific. Even if they do not perfectly reflect brain activity, patterns of several miRNAs have been correlated between the blood and the brain suggesting that blood-based miRNAs can be used as a proxy for activity in the brain of certain miRNAs [194]. Further, the level of miRNAs in several biological fluids including blood, saliva, and urine, have been correlated [195], suggesting that it should be possible to assess the level of miRNAs in the brain with a non-invasive measurement method using easily accessible biological fluids, such as saliva. Moreover, recent advances in miRNA point-of-care technology will simplify the use of miRNAs as biomarkers [196]. To prove the utility of miRNAs as biomarkers of positive and negative experiences will demand several validation steps, not only to check the relevance of the miRNAs to the experiential status of animals, but also to confirm the robustness of the correlation between changes in the brain with changes in an accessible fluid for any miRNA of interest.
Nuclear paraspeckle assembly transcript 1 (NEAT1)
Nuclear paraspeckles are small cellular bodies that are found within the interchromatin space of the cell nucleus [197]. The structural core of a nuclear paraspeckle is nuclear paraspeckle assembly transcript 1 (NEAT1), a long noncoding RNA that binds together the other proteins that make up a paraspeckle [198,199,200]. As well as acting as a scaffold for the paraspeckle, NEAT1 can alter the expression of many genes by impacting on the translation, transcription, and maturation of the microRNAs of those genes [197, 198]. NEAT1 plays a role in cellular defence mechanisms by contributing to the maintenance of mitochondrion homeostasis [201]. NEAT1 is important for neural development and functioning and has been associated with psychiatric diseases including Alzheimer’s, Huntington’s, and Parkinson’s disease [200, 202].
When NEAT1 is knocked out in mice, and those mice are exposed to psychological stress during specific tests, such as the resident-intruder test and elevated plus maze test under bright light, they show abnormal behavioural responses including hyperlocomotion, an altered panic escape response, deficient social interactions, and impaired rhythmic patterns of activity [203]. These observations in NEAT1 knockout mice suggest that changes in NEAT1 could reflect the capacity of an animal to cope with psychological challenge and thus it may hold potential in the assessment of the associated mental state. Interestingly, the level of NEAT1 increases in the peripheral blood of patients with Parkinson’s disease compared to non-affected patients [204] and could reflect the overexpression of NEAT1 in the sustancia nigra of patients with Parkinson’s disease [205]. Levels of NEAT1 in peripheral blood have been proposed as a biomarker of immune and liver diseases [206], and cancer [207]. It seems possible that levels of NEAT1 in blood could serve as a biomarker of the experiential state.
Glycosylated ribonucleic acid (glycoRNAs)
GlycoRNAs were recently discovered in mammals and consist of RNA that has been modified with glycans that contain sialic acid [208, 209]. The majority of glycoRNAs are present on the cell surface and facilitate interactions such as intercellular trafficking and signaling via interaction with cell surface receptors [209, 210]. Amongst the small non-coding RNAs, the Y-RNAs (Y because they are found in the cytoplasm) are glycoRNAs [211]. Y-RNAs are essential for chromosomal DNA replication in vertebrates and are involved in the RNA stability and cellular functioning in response to stress [209, 212]. It has been proposed that glycoRNAs can modify cellular functioning and gene expression because they can interact with other cell surface molecules, such as the sialic acid binding-immunoglobulin lectin-type (Siglec) receptor [213]. In humans, genome wide association studies have identified variants in the gene encoding for Siglec receptors that are associated with neuropsychological conditions such as schizophrenia, bipolar disorder, and autism [213]. Since glycoRNAs bind Siglec receptors they could also be associated with neuropsychological disorders in addition to their involvement in the response to cellular stress. It could therefore be suggested that changes in the circulating level of glycoRNAs could reflect changes in the experiential state, most probably the negative state.
Telomere attrition
Telomeres are repetitive sequences (e.g., TTAGGG) within the DNA sequence at the end of chromosomes. Telomeres protect the coding regions of DNA from damage during normal cellular division and replication, and over time they become progressively shorter through telomere attrition [214, 215]. The rate and distribution of telomere attrition depends on the tissue and varies over time but overall, the average telomere length is correlated between different tissues within an individual [216].
The length of a telomere and its rate of attrition could reflect the cumulative lifetime experience of an animal and could also impact on the capacity of the animal to respond to challenge [217]. When the length of telomeres in white blood cells were monitored over a long term, an increase in the rate of shortening was associated with higher levels of psychological stress such as depression, anxiety, and social isolation in humans, and environmental stress such as lameness and hot weather in cattle [218,219,220,221]. In humans, factors such as optimism, physical activity, and positive social relationships have been suggested to slow the rate of telomere attrition [222,223,224,225]. In addition to causing DNA damage, telomere attrition may influence gene expression and therefore affect the capacity to generate a proper response after exposure to a stimulus. The influence of telomere attrition on gene expression could also impact brain functioning and therefore reflect the effect of cumulative exposure to stressors [226, 227]. A meta-analysis has concluded that telomere length is associated with neuropsychological conditions, with shorter telomeres reflecting the conditions [227]. Changes in telomere length and the rate of attrition are likely to be involved in persistent and long-term changes in positive and negative mental state.
Practically, telomeres can be measured in blood and tissue samples to assess relative telomere length at a single time point, or longitudinal sampling can be used to assess the rate of telomere attrition over time [226, 228]. When a method of measurement to assess telomere attrition is selected, and the results of tests are interpreted, factors such as cell type, animal age, and inter-individual differences need to be considered carefully [229].
Thermobiological markers
Rhythmic changes in core body temperature
The core body temperature (Tc) of endotherms, such as mammals and birds, varies in a circadian manner following a predictable pattern from day to night [230, 231]. For diurnal (awake and active during the day) endotherms, the core body temperature is typically higher during the day (active period) and is lower at night (rest period), creating a repetitive wave-like pattern over time. In contrast, the opposite is observed in nocturnal endotherms, with the temperature higher at night and lower during the day [232]. The pattern persists when an animal is deprived of environmental information about the time of day (such as light/dark cues or variation in environmental temperature), confirming that it is an endogenous circadian rhythm of Tc (CRT) [232]. The changes in Tc appear to be primarily under the control of the circadian system, which has input to the homeostatic thermoregulatory control system that activates thermoregulatory effectors [232].
A cosinor analysis of the CRT can be used to extract parameters that summarize the characteristics of the rhythm: the mesor (Midline Estimating Statistic Of the Rhythm), the amplitude (difference between the mesor and the peak or trough), and the acrophase (time of the peak) [233]. The parameters of the CRT change predictably with various biological factors such as body size, age, sex, activity level, and environmental factors such as feed availability and ambient temperature, in addition to some variation between species and individuals [232,233,234]. Changes in the physiology and behaviour of an animal can affect the circadian rhythm of its Tc [232]. For example, in sheep, changes in feed intake induce changes in the amplitude of the circadian rhythm of Tc, and in lions, rabbits, and rats, the mesor of the circadian rhythm of Tc is affected by pregnancy [235].
Importantly for the subject of this review, the endogenous circadian system not only coordinates bodily functions with each other and with the external environment, but also integrates the zeitgebers and the psychological state in humans and other animals [236]. Disorders of the circadian rhythm in sleep patterns, mainly phase shifts, have been linked to bipolar disorder and seasonal affective disorder [237, 238]. In humans, a phase delay in the CRT has been linked to Alzheimer’s disease [239], while a reduced amplitude of the CRT and irregular shape of the CRT has been observed during episodes of depression, but not altered during manic phases [240].
Stress-induced hyperthermia
Stress-induced hyperthermia (SIH) is an acute response of Tc, involving a rapid and transient increase in Tc in response to psychological stress [241, 242]. The SIH response is usually transient with a rapid increase in Tc after exposure to a stressor which gradually returns to normal once the stressor is removed. The HPA axis and brain areas including the glutaminergic, GABAergic, dopaminergic, and serotonergic pathways are involved in increasing thermogenic activity, which contributes to the observed increase of Tc during SIH [242, 243]. In rodents, the response involves the activation of brown adipose tissue and its associated metabolic heat production, as well as peripheral vasoconstriction [242]. In larger animals, the heat storage that is required for the increase in Tc cannot be achieved by peripheral vasoconstriction and must involve an increase in metabolic heat production, but the source of that heat remains unknown [244]. During the response to some challenges, it is impossible to dissociate the role of the psychological stress, per se, from other activity that involves an increase in metabolic heat production, such as the increase of muscular activity during flight from a predator. However, some psychological stressors do not induce an increase in muscular activity, so the response is independent of exercise hyperthermia. For example, SIH has been observed in response to handling, shearing, restraint, and social defeat in animals [242, 245,246,247,248,249]. Anxiety-like and depressive-like behaviours have also been shown to activate a SIH response [249]. Repeat or chronic psychological stress associated with more depressive-like behaviours has been shown to lead to anticipatory or learned SIH, changes in the CRT (e.g., hyperthermic response during active hours), and an exaggerated SIH to novel stressors [242, 250, 251].
The CRT and the SIH response both are sensitive systems and the parameters of the rhythms (especially the amplitude) and the SIH (the size) can be affected by positive or negative cues. These systems could be used to assess the experience of an animal since they are modified during psychological disorders, as described above. Infrared thermography has some potential in the assessment of negative experiential states but the results are not always conclusive or consistent (for review see [252]). Amongst the different parts of the body, the thermal imaging of lacrimal caruncle seems to be the most promising [252]. Infrared thermography could become a reliable biomarker of experience, but the technology might only be useful in a setting where the animal and the IRT device can be in proximity to each other with minimal environmental interference [252].
While to be truly informative of the CRT and SIH, body temperature needs to be measured deep in the body (the “body core”), the circadian rhythm of skin temperature in humans can be affected by mood [253], suggesting that variation in skin temperature could provide information that might be informative of the experiential state. There is a need to develop smart technology before the CRT or SIH can be used to assess experience in animals. However, changes in the CRT and the SIH response are still good research tools since experimental animals can be instrumented to collect the required data without any need to handle an animal during an experiment.
Challenges in the search for biomarkers of the experiential state in animals
Challenges during the identification phase
Any novel biomarker will need to be validated in a standardized experimental setting as well as controlled real-life situations before it can be used to assess animal welfare in a real-world setting. During experimental validation, any confounding variables that could interfere with the novel biomarker would need to be identified and controlled. For example, Tc can be affected by infection, exercise, and feed intake as well as the experiential state. Ideally, an experimental setting should, where possible, be relevant to in-field conditions to ensure that the results can be transferred from the experimental setting to the real-world setting [254]. It will be critical to validate any biomarker during both positive and negative experiential states. Except for the CRT, no other candidate described in this review seems to provide the capacity to vary in response to the entire range of experience. Therefore, it is likely that multiple biomarkers will be needed to assess changes in the experiential state of an animal.
Other challenges in the development of biomarkers will be the design of experimental paradigms that induce a range of experience and the establishment of thresholds for a negative, neutral, and positive experiential state. The range of experience, as perceived by an animal, will need to be based on other indicators, such as behavioural indicators, rather than a translation of the experience as perceived by a human to a given situation. It seems realistic to first adopt a categorical approach to the classification of experience (positive, neutral, and negative).
Challenges during the implementation stage
For biomarkers to provide meaningful information on the complex dynamics of brain function over time, their measurement will need to be reliable, repeatable, and able to be collected from one of the biological matrices (blood, saliva, urine, etc.) using standardized protocols. Ideally, biomarkers of experience should be measurable when an animal is in its normal setting. The protocol to measure the biomarkers would require minimal or no disturbance to an animal, because if the procedure of sampling induces a change in the state of the animal, then the level of any biomarker will be confounded. For example, it would be preferable to measure biomarkers in easy-to-access matrices to avoid triggering any physiological responses to the sampling technique that may have an influence on the experiential state. Several techniques have been developed to measure biological samples in matrices other than blood and saliva, including in urine, feces, and hair. Moreover, the measurement of any biomarker of experience in a normal setting will require the techniques of sampling and analysis to be commercially feasible and practical for measuring both at an individual and group level [254, 255].
The case of glucocorticoids provides a good illustration of the need for the development of technology and careful sampling strategies. Glucocorticoids have been routinely measured to assess the response to stress and are commonly considered as an indicator of a negative welfare state. While glucocorticoids are often measured in plasma and serum in an experimental setting, it is commonly considered preferable to measure glucocorticoids or their metabolites in other biological matrices including saliva, urine, feces, and hair because these matrices can be sampled without the risk of inducing a glucocorticoid response [256,257,258]. The collection of a saliva sample can be achieved using some forms of environmental enrichment (for example toys), as has been done in pigs using cotton ropes to measure miRNAs in saliva for viral detection at a herd level [259] and chewable silicone sticks to measure saliva cortisol [256]. Saliva samples can also be used to measure other markers discussed in this review, such as the ratio of cortisol to DHEA in pigs and BDNF in rats [260, 261]. The measurement of glucocorticoids in each type of sample provides different information on the physiology of an animal due to differences in time between synthesis, transport, deposition in the matrix, and metabolism [49, 50, 54]. For example, the measurement of cortisol in saliva is often used to provide information on acute stress in response to an event, whereas hair samples capture information on chronic stress over weeks, months, or longer [257, 262].
There are many settings where it would be useful to measure biomarkers remotely with minimal need for interaction between humans and an animal. Techniques such as the bioacoustic analysis of vocalizations, analysis of facial expressions from video, or belts that transmit heart rate, although still limited in their application in the field, show promise for the automated assessment of animal welfare and perhaps the experiential state [41, 45, 46, 263, 264]. Technology is already available to remotely measure body temperature, heart rate, and locomotor activity in animals in the field, but these technologies remain expensive and rely on infrastructure to transfer data that could be used to assess the emotional state in real-time.
Challenges to the practical use of biomarkers of mental state
In an ideal world, biomarkers of the experiential state of an animal could be used to develop a model that could predict the experiential state of an animal in a given situation. The development of such a model would involve the measurement of multiple indicators of brain function over short and long periods. The volume and variety of the data obtained from such an exercise would far outstrip the capacity of a simple analytical algorithm. To obtain a reliable and predictive model of experiential state from the complex dynamics of brain function, meaningful datasets must be acquired. To achieve meaningful datasets, repeated measurements should be taken from multiple replicates. Ideally, the samples that will form the training dataset of the model should be measured from experiments conducted across multiple facilities using a standardized protocol.
To be meaningful in a practical sense, the data on biomarkers of experiential state in animals must be relevant to the decisions that people need to make about the animals under their care. Models of biomarkers that reflect the experiential state of animals must provide the decision makers with actionable outputs that are compatible with the procedures and settings within which the animals are being kept. One strategy that has been trialed for the development of meaningful models of complex, real-world dynamics in other domains has been to involve non-scientist decision-makers and stakeholders in the modelling project [265]. Such a participatory modelling approach is thought to facilitate the integration of knowledge and ensure the ‘‘social robustness’’ of the outputs of the model and decision supports [266]. In the context of animal welfare, the term “stakeholders” goes beyond people with animals under their direct care to include anyone who is concerned about the welfare of the animals, including customers, auditors, regulators, and members of the public. Substantive approaches to participatory deliberation are based on the conviction that the quality of a decision is improved if such stakeholders are involved in the decision making process [267]. To ensure that information about the experience of animals is meaningful in practice, a collaborative approach should be used, such that the research process is designed and conducted with all stakeholders on equal footing understanding that there will be various degrees of participation [268].
Once a meaningful training dataset for biomarkers of the experiential state of an animal has been collected, the dataset should be pre-processed to remove any irrelevant data before a predictive model can be produced. In large and complex datasets, data pre-processing is the most critical stage in ensuring that only relevant information is retained without bias [269]. The cleaning step is challenging, as many factors, such as insufficient data, technical errors, and inaccuracies during data entry, can hinder the production of a clean and relevant dataset. Once that pre-processing is complete, then a predictive model can be produced using multivariate algorithms that use machine learning and/or deep learning techniques. The predictive model is produced by “learning” from the training sets that are acquired earlier in the process through either a supervised or an unsupervised approach. During supervised learning, the model is trained using a dataset that has been assigned with many observations, each containing several features and clinical outcomes for an animal. Conversely, an unsupervised learning model aims to identify patterns from the data without having access to classifications, such as a phenotype. As a final step, the model requires rigorous validation against an external dataset that was collected from an independent cohort of animals to address any potential selection bias. It is only after these time-consuming, and costly, steps are completed that the establishment of an accurate and predictive model can be achieved to make predictive and meaningful decisions about the experiential state of an animal.
Conclusion
Although the behavioural, physiological, and neurobiological indicators that are currently available can provide valuable information on the welfare state of an animal, they do not provide the best assessment of the experiential state of that animal. We have proposed several candidate biomarkers that, based on their main function, include endocrine, oxidative stress, non-coding molecular, and thermobiological markers that may be correlates of the experiential state of an animal because they have been found to be affected by psychological or neurophysiological disorders in humans or in animal models of those same disorders. There is a need for further research to validate and improve our understanding of these biomarkers of experiential state and their dynamics. It seems unlikely that any single biomarker will cover the full spectrum of experience from negative to positive. Aside from validating these biomarkers, the assessment of experiential state will be most relevant to the assessment of animal welfare if the assessment can be conducted in real-time and anywhere. Therefore, further technological development is needed to facilitate the adoption of these novel biomarkers by the end users with animals under their care.
Availability of data and materials
None of the data was deposited in an official repository.
Abbreviations
- 2-AG:
-
2-Arachidonoylglycerol
- AEA:
-
Arachidonylethanolamine
- BDNF:
-
Brain-derived neurotrophic factor
- CBR1:
-
Cannabinoid receptor subtype 1
- CSF:
-
Cerebrospinal fluid
- CRT:
-
Circadian rhythm of core body temperature
- DNA:
-
Deoxyribonucleic acid
- ECBs:
-
Endocannabinoids
- FGF2:
-
Fibroblast growth factor 2
- GH:
-
Growth hormone
- GlycoRNA:
-
Glycosylated ribonucleic acid
- HPA axis:
-
Hypothalamic–pituitary–adrenal axis
- IGF-1:
-
Insulin-like growth factor 1
- IGFBPs:
-
Insulin-like growth factor binding proteins
- lncRNA:
-
Long noncoding ribonucleic acid
- miRNA:
-
Micro-ribonucleic acid
- mRNA:
-
Messenger ribonucleic acid
- NEAT1:
-
Nuclear paraspeckle assembly transcript 1
- ROS:
-
Reactive oxygen species
- RONS:
-
Reactive nitrogen species
- SIH:
-
Stress-induced hyperthermia
- Tc :
-
Core body temperature
References
Duncan IJH. Animal welfare: a brief history. In: Hild S, Schweitzer L, editors. Animal Welfare: from Science to Law. La Fondation Droit Animal: Éthique et Sciences. Paris; 2019. p. 13–9.
Cornish A, Wilson B, Raubenheimer D, McGreevy P. Demographics regarding belief in non-human animal sentience and emotional empathy with animals: a pilot study among attendees of an animal welfare symposium. Animals. 2018;8:174.
Fraser D. The globalisation of farm animal welfare. Rev Sci Tech. 2014;33:33–8.
Appleby M, Olsson I, Galindo F. Animal welfare. 3rd ed. Wallingford: CAB International; 2018.
Whittaker A, Marsh LE. The role of behavioural assessment in determining positive affective states. CAB Reviews. 2019;14:1–13.
Hemsworth PH, Mellor DJ, Cronin GM, Tilbrook AJ. Scientific assessment of animal welfare. New Zeal Vet J. 2015;63:24–30.
Crump A, Arnott G, Bethell EJ. Affect-driven attention biases as animal welfare indicators: review and methods. Animals. 2018;8:136.
Lawrence AB, Vigors B, Sandøe P. What is so positive about positive animal welfare?—a critical review of the literature. Animals. 2019;9:783.
Mellor DJ. Positive animal welfare states and reference standards for welfare assessment. New Zeal Vet J. 2015;63:17–23.
Radkowska I, Godyń D, Fic K. Stereotypic behaviour in cattle, pigs and horses-a review. Anim Sci Pap Rep. 2020;38:303–19.
Ridge EE, Foster MJ, Daigle CL. Effect of diet on non-nutritive oral behavior performance in cattle: a systematic review. Livest Sci. 2020;238:104063.
Cronin GM, Glatz PC. Causes of feather pecking and subsequent welfare issues for the laying hen: a review. Anim Prod Sci. 2020;61:990–1005.
Dalton HA, Wood BJ, Torrey S. Injurious pecking in domestic turkeys: development, causes, and potential solutions. Worlds Poult Sci J. 2013;69:865–76.
Sonoda L, Fels M, Oczak M, Vranken E, Ismayilova G, Guarino M, et al. Tail biting in pigs. Berl Munch Tierarztl Wochenschr. 2013;126:104–12.
Henry M, Jansen H, Amezcua M del R, O’sullivan TL, Niel L, Shoveller AK, et al. Tail-biting in pigs: a scoping review. Animals. 2021;11:2002.
Nicol CJ. Environmental choices of farm animals. BSAP Occasional Publication. 1997;20:35–43.
Miller LJ, Vicino GA, Sheftel J, Lauderdale LK. Behavioral diversity as a potential indicator of positive animal welfare. Animals. 2020;10(7):1211.
Ahloy-Dallaire J, Espinosa J, Mason G. Play and optimal welfare: does play indicate the presence of positive affective states? Behav Process. 2018;156:3–15.
Held SDE, Špinka M. Animal play and animal welfare. Anim Behav. 2011;81:891–9.
Daigle CL, Hubbard AJ, Grandin T. The use of traditional fear tests to evaluate different emotional circuits in cattle. J Vis Exp. 2020;158:e60641.
Forkman B, Boissy A, Meunier-Salaün MC, Canali E, Jones RB. A critical review of fear tests used on cattle, pigs, sheep, poultry and horses. Physiol Behav. 2007;92:340–74.
Clegg ILK, Delfour F. Cognitive judgement bias is associated with frequency of anticipatory behavior in bottlenose dolphins. Zoo Biol. 2018;37:67–73.
Stamp Dawkins M. The science of animal welfare. Understanding what animals want. Oxford: Oxford University Press; 2021.
Mattiello S, Battini M, de Rosa G, Napolitano F, Dwyer C. How can we assess positive welfare in ruminants? Animals. 2019;9:758.
Roelofs S, Boleij H, Nordquist RE, van der Staay FJ. Making decisions under ambiguity: judgment bias tasks for assessing emotional state in animals. Front Behav Neurosci. 2016;10:119.
Mendl M, Burman OHP, Parker RMA, Paul ES. Cognitive bias as an indicator of animal emotion and welfare: emerging evidence and underlying mechanisms. Appl Anim Behav Sci. 2009;118:161–81.
Baciadonna L, Mcelligott AG. The use of judgement bias to assess welfare in farm livestock. Anim Welf. 2015;24:81–91.
Bethell EJ. A “how-to” guide for designing judgment bias studies to assess captive animal welfare. J Appl Anim Welf Sci. 2015;18:S18–42.
Ferguson D, Colditz I, Collins T, Matthews L, Hemsworth P. Assessing the welfare of farm animals-a review. Progress Report - APL Project No 2011/1036.421. Canberra: Australian Pork Limited; 2012.
Fleming PA, Clarke T, Wickham SL, Stockman CA, Barnes AL, Collins T, et al. The contribution of Qualitative Behavioural Assessment to appraisal of livestock welfare. Anim Prod Sci. 2016;56:1569–78.
Rose P, Riley L. The use of Qualitative Behavioural Assessment to zoo welfare measurement and animal husbandry change. J Zoo Aquar Res. 2019;7:150–61.
Patel F, Wemelsfelder F, Ward SJ. Using Qualitative Behaviour Assessment to investigate human-animal relationships in zoo-housed giraffes (Giraffa camelopardalis). Animals. 2019;9:381.
Yon L, Williams E, Harvey ND, Asher L. Development of a behavioural welfare assessment tool for routine use with captive elephants. PLoS ONE. 2019;14:e0210783.
Travnik IC, Sant’Anna AC. Do you see the same cat that I see? relationships between Qualitative Behaviour Assessment and indicators traditionally used to assess temperament in domestic cats. Anim Welf. 2021;30:211–23.
Stubsjøen SM, Moe RO, Bruland K, Lien T, Muri K. Reliability of observer ratings: Qualitative Behaviour Assessments of shelter dogs using a fixed list of descriptors. Vet Anim Sci. 2020;10:100145.
Walker JK, Dale AR, D’Eath RB, Wemelsfelder F. Qualitative Behaviour Assessment of dogs in the shelter and home environment and relationship with quantitative behaviour assessment and physiological responses. Appl Anim Behav Sci. 2016;184:97–108.
Diaz-Lundahl S, Hellestveit S, Stubsjøen SM, Phythian CJ, Moe RO, Muri K. Intra- and inter-observer reliability of Qualitative Behaviour Assessments of housed sheep in Norway. Animals. 2019;9:569.
Brscic M, Otten ND, Contiero B, Kirchner MK. Investigation of a standardized Qualitative Behaviour Assessment and exploration of potential influencing factors on the emotional state of dairy calves. Animals. 2019;9:757.
Muri K, Stubsjøen SM, Vasdal G, Moe RO, Granquist EG. Associations between qualitative behaviour assessments and measures of leg health, fear and mortality in Norwegian broiler chicken flocks. Appl Anim Behav Sci. 2019;211:47–53.
Minero M, Dalla Costa E, Dai F, Canali E, Barbieri S, Zanella A, et al. Using qualitative behaviour assessment (QBA) to explore the emotional state of horses and its association with human-animal relationship. Appl Anim Behav Sci. 2018;204:53–9.
Descovich KA, Wathan J, Leach MC, Buchanan-Smith HM, Flecknell P, Farningham D, et al. Facial expression: an under-utilised tool for the assessment of welfare in mammals. Altex. 2017;34:409–29.
Lu Y, Mahmoud M, Robinson P. Estimating sheep pain level using facial action unit detection. In: Proceedings - 12th IEEE International Conference on Automatic Face and Gesture Recognition. Washington: Institute of Electrical and Electronics Engineers Inc; 2017. p. 394–9.
Proctor HS, Carder G. Looking into the eyes of a cow: Can eye whites be used as a measure of emotional state? Appl Anim Behav Sci. 2017;186:1–6.
Reefmann N, Bütikofer Kaszàs F, Wechsler B, Gygax L. Ear and tail postures as indicators of emotional valence in sheep. Appl Anim Behav Sci. 2009;118:199–207.
Laurijs KA, Briefer EF, Reimert I, Webb LE. Vocalisations in farm animals: a step towards positive welfare assessment. Appl Anim Behav Sci. 2021;236:105264.
Adelman JS, Estes Z, Cossu M. Emotional sound symbolism: languages rapidly signal valence via phonemes. Cognition. 2018;175:122–30.
Briefer EF, Le Comber S. Vocal expression of emotions in mammals: mechanisms of production and evidence. J Zool. 2012;288:1–20.
Tilbrook AJ, Ralph CR. Neurophysiological assessment of animal welfare. Anim Prod Sci. 2017;57:2370–5.
Tilbrook AJ, Ralph CR. Hormones, stress and the welfare of animals. Anim Prod Sci. 2018;58:408–15.
Ralph CR, Tilbrook AJ. Invited review: the usefulness of measuring glucocorticoids for assessing animal welfare. J Anim Sci. 2016;94:457–70.
Manteuffel C, Spitschak M, Ludwig C, Wirthgen E. New perspectives in the objective evaluation of animal welfare, with focus on the domestic pig. J Appl Anim Welf Sci. 2023;26:518–29.
Boissy A, Manteuffel G, Jensen MB, Moe RO, Spruijt B, Keeling LJ, et al. Assessment of positive emotions in animals to improve their welfare. Physiol Behav. 2007;92:375–97.
Turner AI, Rivalland ETA, Clarke IJ, Tilbrook AJ. Stressor specificity of sex differences in hypothalamo-pituitary-adrenal axis activity: cortisol responses to exercise, endotoxin, wetting, and isolation/restraint stress in gonadectomized male and female sheep. Endocrinology. 2010;151:4324–31.
Tilbrook AJ. Effects of stress on reproduction in non-rodent mammals: the role of glucocorticoids and sex differences. Rev Reprod. 2017;5:105–13.
Parrott RF, Bradshaw RH, Lloyd DM, Goode JA. Effects of transport and indomethacin on telemetered body temperature and release of cortisol and prolactin in pre-pubertal pigs. Res Vet Sci. 1998;64:51–5.
Dobson H, Fergani C, Routly JE, Smith RF. Effects of stress on reproduction in ewes. Anim Reprod Sci. 2012;130:135–40.
Morris MJ, Kaneko K, Walker SL, Jones DN, Routly JE, Smith RF, et al. Influence of lameness on follicular growth, ovulation, reproductive hormone concentrations and estrus behavior in dairy cows. Theriogenology. 2011;76:658–68.
Qu H, Ajuwon KM. Metabolomics of heat stress response in pig adipose tissue reveals alteration of phospholipid and fatty acid composition during heat stress. J Anim Sci. 2018;96:3184–95.
García-Bueno B, Madrigal JLM, Pérez-Nievas BG, Leza JC. Stress mediators regulate brain prostaglandin synthesis and peroxisome proliferator-activated receptor-γ activation after stress in rats. Endocrinology. 2008;149:1969–78.
Morimoto A, Watanabe T, Morimoto K, Nakamori T, Murakami N. Possible involvement of prostaglandins in psychological stress-induced responses in rats. J Physiol. 1991;443:421–9.
Cavallini D, Mammi LME, Buonaiuto G, Palmonari A, Valle E, Formigoni A. Immune-metabolic-inflammatory markers in Holstein cows exposed to a nutritional and environmental stressing challenge. J Anim Physiol Anim Nutr. 2021;105:42–55.
Eckersall D. Acute phase protein: biomarkers of disease in cattle and sheep. Cattle Pract. 2007;15:240–3.
Cywińska A, Szarska E, Górecka R, Witkowski L, Hecold M, Bereznowski A, et al. Acute phase protein concentrations after limited distance and long distance endurance rides in horses. Res Vet Sci. 2012;93:1402–6.
Cerón JJ, Eckersall PD, Martínez-Subiela S. Acute phase proteins in dogs and cats: current knowledge and future perspectives. Vet Clin Pathol. 2005;34:85–99.
Cray C, Watson T, Rodriguez M, Arheart KL. Application of galactomannan analysis and protein electrophoresis in the diagnosis of Aspergillosis in avian species. J Zoo Wildl Med. 2009;40:64–70.
Yamamoto S, Motomura A, Akahoshi A, Takahashi K, Minami H. Immunoglobulin secretions in the mesenteric lymph node in stressed rats. J Nutr Sci Vitaminol. 2009;55:191–4.
Zoppi S, Madrigal JLM, Pérez-Nievas BG, Marín-Jiménez I, Caso JR, Alou L, et al. Endogenous cannabinoid system regulates intestinal barrier function in vivo through cannabinoid type 1 receptor activation. Am J Physiol Gastrointest Liver Physiol. 2012;302:565–71.
Royo F, Lyberg K, Abelson K, Carlsson HE, Hau J. Effect of repeated confined single housing of young pigs on faecal excretion of cortisol and IgA. Scand J Clin Lab Invest. 2005;32:33–7.
Goshen I, Kreisel T, Ben-Menachem-Zidon O, Licht T, Weidenfeld J, Ben-Hur T, et al. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry. 2008;13:717–28.
Kubera M, Maes M, Holan V, Basta-Kaim A, Roman A, Shani J. Prolonged desipramine treatment increases the production of interleukin-10, an anti-inflammatory cytokine, in C57BL/6 mice subjected to the chronic mild stress model of depression. J Affect Disord. 2001;63:171–8.
Sporer KRB, Xiao L, Tempelman RJ, Burton JL, Earley B, Crowe MA. Transportation stress alters the circulating steroid environment and neutrophil gene expression in beef bulls. Vet Immunol Immunopathol. 2008;121:300–20.
Fustini M, Galeati G, Gabai G, Mammi LE, Bucci D, Baratta M, et al. Overstocking dairy cows during the dry period affects dehydroepiandrosterone and cortisol secretion. J Dairy Sci. 2017;100:620–8.
Schurr MJ, Fabian TC, Croce MA, Varnavas LE, Proctor KG. Dehydroepiandrosterone, an endogenous immune modulator, after traumatic shock. Shock. 1997;7:55–9.
Lanci A, Mariella J, Ellero N, Faoro A, Peric T, Prandi A, et al. Hair cortisol and DHEA-S in foals and mares as a retrospective picture of feto-maternal relationship under physiological and pathological conditions. Animals. 2022;12:1266.
Whitham JC, Bryant JL, Miller LJ. Beyond glucocorticoids: integrating dehydroepiandrosterone (DHEA) into animal welfare research. Animals. 2020;10:1381.
Coulon M, Nowak R, Peyrat J, Chandèze H, Boissy A, Boivin X. Do lambs perceive regular human stroking as pleasant? behavior and heart rate variability analyses. PLoS ONE. 2015;10:e0118617.
Zupan M, Framstad T, Zanella AJ. Behaviour, heart rate, and heart rate variability in pigs exposed to novelty. Revista Brasileira de Zootecnia. 2016;45:121–9.
Clapp JB, Croarkin S, Dolphin C, Lyons SK. Heart rate variability: a biomarker of dairy calf welfare. Anim Prod Sci. 2015;55:1289.
Zupan M, Buskas J, Altimiras J, Keeling LJ. Assessing positive emotional states in dogs using heart rate and heart rate variability. Physiol Behav. 2016;155:102–11.
Ille N, von Lewinski M, Erber R, Wulf M, Aurich J, Möstl E, et al. Effects of the level of experience of horses and their riders on cortisol release, heart rate and heart-rate variability during a jumping course. Anim Welf. 2013;22:457–65.
Bergamasco L, Osella MC, Savarino P, Larosa G, Ozella L, Manassero M, et al. Heart rate variability and saliva cortisol assessment in shelter dog: human–animal interaction effects. Appl Anim Behav Sci. 2010;125:56–68.
Rashamol VP, Sejian V, Bagath M, Krishnan G, Archana PR, Bhatta R. Physiological adaptability of livestock to heat stress: an updated review. J Anim Behav Biometeorol. 2018;6:62–71.
Berihulay H, Abied A, He X, Jiang L, Ma Y. Adaptation mechanisms of small ruminants to environmental heat stress. Animals. 2019;9:75.
Caulfield MP, Cambridge H, Foster SF, McGreevy PD. Heat stress: a major contributor to poor animal welfare associated with long-haul live export voyages. The Vet J. 2014;199:223–8.
Lopedote M, Valentini S, Musella V, Vilar JM, Spinella G. Changes in pulse rate, respiratory rate and rectal temperature in working dogs before and after three different field trials. Animals. 2020;10:733.
Panksepp J. Affective neuroscience: the foundations of human and animal emotions. New York: Oxford University Press; 1998.
LeDoux JE. Emotion: clues from the brain. Annu Rev Psychol. 1995;46:209–35.
Paul ES, Harding EJ, Mendl M. Measuring emotional processes in animals: the utility of a cognitive approach. Neurosci Biobehav Rev. 2005;29:469–91.
Kremer L, Klein Holkenborg SEJ, Reimert I, Bolhuis JE, Webb LE. The nuts and bolts of animal emotion. Neurosci Biobehav Rev. 2020;113:273–86.
Chincarini M, Qiu L, Spinelli L, Torricelli A, Minero M, Costa ED, et al. Evaluation of sheep anticipatory response to a food reward by means of functional near-infrared spectroscopy. Animals. 2019;9:11.
Chincarini M, Dalla Costa E, Qiu L, Spinelli L, Cannas S, Palestrini C, et al. Reliability of fNIRS for noninvasive monitoring of brain function and emotion in sheep. Sci Rep. 2020;10:14726.
Iversen SD, Iversen LL. Dopamine: 50 years in perspective. Trends Neurosci. 2007;30:188–93.
Olguín HJ, Guzmán DC, García EH, Mejía GB. The role of dopamine and its dysfunction as a consequence of oxidative stress. Oxid Med Cell Longev. 2016;2016:9730467.
Alexander R, Aragón OR, Bookwala J, Cherbuin N, Gatt JM, Kahrilas IJ, et al. The neuroscience of positive emotions and affect: Implications for cultivating happiness and wellbeing. Neurosci Biobehav Rev. 2021;121:220–49.
Lürzel S, Bückendorf L, Waiblinger S, Rault JL. Salivary oxytocin in pigs, cattle, and goats during positive human-animal interactions. Psychoneuroendocrinology. 2020;115:104636.
Busnelli M, Chini B. Molecular basis of oxytocin receptor signalling in the brain: what we know and what we need to know. In: Hurlemann R, Grinevich V, editors. Behavioral pharmacology of neuropeptides: Oxytocin. Cham: Springer; 2017. p. 3–29.
Olazábal DE. Role of oxytocin in parental behaviour. J Neuroendocrinol. 2018;30:e12594.
Cochran DM, Fallon D, Hill M, Frazier JA. The role of oxytocin in psychiatric disorders. Harv Rev Psychiatry. 2013;21:219–47.
Morhenn V, Park J, Piper E, Zak P. Monetary sacrifice among strangers is mediated by endogenous oxytocin release after physical contact. Evol Hum Behav. 2008;29:375–83.
D’aniello B, Mastellone V, Pinelli C, Scandurra A, Musco N, Tudisco R, et al. Serum oxytocin in cows is positively correlated with caregiver interactions in the impossible task paradigm. Animals. 2022;12:276.
Uvnäs-Moberg K, Arn I, Magnusson D. The psychobiology of emotion: the role of the oxytocinergic system. Int J Behav Med. 2005;12:59–65.
Tops M, van Peer JM, Korf J, Wijers AA, Tucker DM. Anxiety, cortisol, and attachment predict plasma oxytocin. Psychophysiology. 2007;44:444–9.
Engert V, Koester AM, Riepenhausen A, Singer T. Boosting recovery rather than buffering reactivity: higher stress-induced oxytocin secretion is associated with increased cortisol reactivity and faster vagal recovery after acute psychosocial stress. Psychoneuroendocrinology. 2016;74:111–20.
Young Kuchenbecker S, Pressman SD, Celniker J, Grewen KM, Sumida KD, Jonathan N, et al. Oxytocin, cortisol, and cognitive control during acute and naturalistic stress. Stress. 2021;24:370–83.
Cardoso C, Ellenbogen MA, Orlando MA, Bacon SL, Joober R. Intranasal oxytocin attenuates the cortisol response to physical stress: a dose–response study. Psychoneuroendocrinology. 2013;38:399–407.
Yayou KI, Ito S, Kasuya E, Sutoh M, Ohkura S, Okamura H. Intracerebroventricularly administered oxytocin attenuated cortisol secretion, but not behavioral responses, during isolation in Holstein steers. J Vet Med Sci. 2008;70:665–71.
Chen S, Sato S. Role of oxytocin in improving the welfare of farm animals — a review. Asian-Australas J Anim Sci. 2017;30:449.
Coria-Avila GA, Pfaus JG, Orihuela A, Domínguez-Oliva A, José-Pérez N, Hernández LA, et al. The neurobiology of behavior and its applicability for animal welfare: a review. Animals. 2022;12:928.
Rault JL, van den Munkhof M, Buisman-Pijlman FTA. Oxytocin as an indicator of psychological and social well-being in domesticated animals: a critical review. Front Psychol. 2017;8:1521.
LeRoith D, Holly JMP, Forbes BE. Insulin-like growth factors: ligands, binding proteins, and receptors. Mol Metab. 2021;52:101245.
Mesotten D, van den Berghe G. Changes within the GH/IGF-I/IGFBP axis in critical illness. Crit Care Clin. 2006;22:17–28.
Lewitt MS, Boyd GW. The role of insulin-like growth factors and insulin-like growth factor–binding proteins in the nervous system. Biochem Insights. 2019;12:117862641984217.
Picillo M, Pivonello R, Santangelo G, Pivonello C, Savastano R, Auriemma R, et al. Serum IGF-1 is associated with cognitive functions in early, drug-naïve Parkinson’s disease. PLoS ONE. 2017;12:e0186508.
Cassilhas RC, Antunes HKM, Tufik S, de Mello MT. Mood, anxiety, and serum IGF-1 in elderly men given 24 weeks of high resistance exercise. Percept Mot Skills. 2010;110:265–76.
Soto M, Cai W, Konishi M, Kahn CR. Insulin signaling in the hippocampus and amygdala regulates metabolism and neurobehavior. Proc Natl Acad Sci U S A. 2019;116:6379–84.
Wirthgen E, Kunze M, Goumon S, Walz C, Höflich C, Spitschak M, et al. Interference of stress with the somatotropic axis in pigs – lights on new biomarkers. Sci Rep. 2017;7:12055.
Bach LA. 40 years of IGF1: IGF-binding proteins. J Mol Endocrinol. 2018;61:T11-28.
Allard JB, Duan C. IGF-binding proteins: why do they exist and why are there so many? Front Endocrinol. 2018;9:117.
Murer MG, Yan Q, Raisman-Vozari R. Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease. Prog Neurobiol. 2001;63:71–124.
Cattaneo A, Cattane N, Begni V, Pariante CM, Riva MA. The human BDNF gene: peripheral gene expression and protein levels as biomarkers for psychiatric disorders. Transl Psychiatry. 2016;6:e958.
Yuluǧ B, Ozan E, Gönül AS, Kilic E. Brain-derived neurotrophic factor, stress and depression: a minireview. Brain Res Bull. 2009;78:267–9.
Chourbaji S, Brandwein C, Gass P. Altering BDNF expression by genetics and/or environment: Impact for emotional and depression-like behaviour in laboratory mice. Neurosci Biobehav Rev. 2011;35:599–611.
Murakami S, Imbe H, Morikawa Y, Kubo C, Senba E. Chronic stress, as well as acute stress, reduces BDNF mRNA expression in the rat hippocampus but less robustly. Neurosci Res. 2005;53:129–39.
Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci. 1995;15:7539–47.
Shirayama Y, Chen ACH, Nakagawa S, Russell DS, Duman RS. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci. 2002;22:3251–61.
Tyler WJ, Alonso M, Bramham CR, Pozzo-Miller LD. From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning. Learn Mem. 2002;9:224–37.
Falkenberg T, Mohammed AK, Henriksson B, Kan Persson H, Winblad B, Lindefors N. Increased expression of brain-derived neurotrophic factor mRNA in rat hippocampus is associated with improved spatial memory and enriched environment. Neurosci Lett. 1992;138:153–6.
Ickes BR, Pham TM, Sanders LA, Albeck DS, Mohammed AH, Granholm AC. Long-term environmental enrichment leads to regional increases in neurotrophin levels in rat brain. Exp Neurol. 2000;164:45–52.
Gordon NS, Burke S, Akil H, Watson SJ, Panksepp J. Socially-induced brain “fertilization”: play promotes brain derived neurotrophic factor transcription in the amygdala and dorsolateral frontal cortex in juvenile rats. Neurosci Lett. 2003;341:17–20.
Yamada K, Nabeshima T. Brain-derived neurotrophic factor/TrkB signaling in memory processes. J Pharmacol Sci. 2003;91:267–70.
Klein AB, Williamson R, Santini MA, Clemmensen C, Ettrup A, Rios M, et al. Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol. 2011;14:347–53.
Beeri MS, Sonnen J. Brain BDNF expression as a biomarker for cognitive reserve against Alzheimer disease progression. Neurology. 2016;86:702–3.
Mandel AL, Ozdener H, Utermohlen V. Brain-derived neurotrophic factor in human saliva: ELISA optimization and biological correlates. J Immunoassay Immunochem. 2011;32:18–30.
Vrijen C, Schenk HM, Hartman CA, Oldehinkel AJ. Measuring BDNF in saliva using commercial ELISA: results from a small pilot study. Psychiatry Res. 2017;254:340–6.
Balietti M, Giuli C, Conti F. Peripheral blood brain-derived neurotrophic factor as a biomarker of Alzheimer’s disease: are there methodological biases. Mol Neurobiol. 2018;55:6661–72.
Foltran RB, Diaz SL. BDNF isoforms: a round trip ticket between neurogenesis and serotonin? J Neurochem. 2016;138:204–21.
Gejl AK, Enevold C, Bugge A, Andersen MS, Nielsen CH, Andersen LB. Associations between serum and plasma brain-derived neurotrophic factor and influence of storage time and centrifugation strategy. Sci Rep. 2019;9:9655.
Wessels JM, Agarwal RK, Somani A, Verschoor CP, Agarwal SK, Foster WG. Factors affecting stability of plasma brain-derived neurotrophic factor. Sci Rep. 2020;10:20232.
Sargin D. The role of the orexin system in stress response. Neuropharmacology. 2019;154:68–78.
Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci. 1998;18:9996–10015.
Seigneur E, de Lecea L. Hypocretin (orexin) replacement therapies. Med Drug Discov. 2020;8:100070.
Jacobson LH, Hoyer D, Lecea L. Hypocretins (orexins): the ultimate translational neuropeptides. J Intern Med. 2022;291:533–56.
Yeoh JW, Campbell EJ, James MH, Graham BA, Dayas CV. Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls. Front Neurosci. 2014;8:36.
Giardino WJ, de Lecea L. Hypocretin (orexin) neuromodulation of stress and reward pathways. Curr Opin Neurobiol. 2014;29:103–8.
Hopf FW. Recent perspectives on orexin/hypocretin promotion of addiction-related behaviors. Neuropharmacology. 2020;168:108013.
Allard JS, Tizabi Y, Shaffery JP, Ovid Trouth C, Manaye K. Stereological analysis of the hypothalamic hypocretin/orexin neurons in an animal model of depression. Neuropeptides. 2004;38:311–5.
Chung HS, Kim JG, Kim JW, Kim HW, Yoon BJ. Orexin administration to mice that underwent chronic stress produces bimodal effects on emotion-related behaviors. Regul Pept. 2014;194–195:16–22.
Lindström M, Schinkelshoek M, Tienari PJ, Kukkonen JP, Renkonen R, Fronczek R, et al. Orexin-A measurement in narcolepsy: a stability study and a comparison of LC-MS/MS and immunoassays. Clin Biochem. 2021;90:34–9.
Kukkonen JP. What do I talk about when I talk about measuring CNS orexin-A? Considerations of orexin-A measurements in clinical and preclinical setting. Med Drug Discov. 2021;11:100101.
McLaughlin RJ, Hill MN, Gorzalka BB. A critical role for prefrontocortical endocannabinoid signaling in the regulation of stress and emotional behavior. Neurosci Biobehav Rev. 2014;42:116–31.
van der Stelt M, Hansen HH, Veldhuis WB, Bär PR, Nicolay K, Veldink GA, et al. Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases. Neurotox Res. 2003;5:183–200.
Finn DP, Haroutounian S, Hohmann AG, Krane E, Soliman N, Rice ASC. Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies. Pain. 2021;162:S5–25.
deRoon-Cassini TA, Stollenwerk TM, Beatka M, Hillard CJ. Meet your stress management professionals: the endocannabinoids. Trends Mol Med. 2020;26:953–68.
Petrie GN, Nastase AS, Aukema RJ, Hill MN. Endocannabinoids, cannabinoids and the regulation of anxiety. Neuropharmacology. 2021;195:108626.
Rahman SMK, Uyama T, Hussain Z, Ueda N. Roles of endocannabinoids and endocannabinoid-like molecules in energy homeostasis and metabolic regulation: a nutritional perspective. Annu Rev Nutr. 2021;41:177–202.
Hillard CJ. Circulating endocannabinoids: from whence do they come and where are they going? Neuropsychopharmacology. 2018;43:155–72.
Ye Q, Zeng X, Cai S, Qiao S, Zeng X. Mechanisms of lipid metabolism in uterine receptivity and embryo development. Trends Endocrinol Metab. 2021;32:1015–30.
Zachut M, Kra G, Moallem U, Livshitz L, Levin Y, Udi S, et al. Characterization of the endocannabinoid system in subcutaneous adipose tissue in periparturient dairy cows and its association to metabolic profiles. PLoS ONE. 2018;13:e0205996.
Myers MN, Zachut M, Tam J, Contreras GA. A proposed modulatory role of the endocannabinoid system on adipose tissue metabolism and appetite in periparturient dairy cows. J Anim Sci Biotechnol. 2021;12:21.
Kuhla B, Kaever V, Tuchscherer A, Kuhla A. Involvement of plasma endocannabinoids and the hypothalamic endocannabinoid system in increasing feed intake after parturition of dairy cows. Neuroendocrinology. 2020;110:246–57.
Iannotti FA, Di Marzo V. The gut microbiome, endocannabinoids and metabolic disorders. J Endocrinol. 2021;248:83–97.
Celi P. Biomarkers of oxidative stress in ruminant medicine. Immunopharmacol Immunotoxicol. 2011;33:233–40.
Ursini F, Maiorino M, Forman HJ. Redox homeostasis: The golden mean of healthy living. Redox Biol. 2016;8:205–15.
Valacchi G, Virgili F, Cervellati C, Pecorelli A. OxInflammation: from subclinical condition to pathological biomarker. Front Physiol. 2018;9:858.
Niedzielska E, Smaga I, Gawlik M, Moniczewski A, Stankowicz P, Pera J, et al. Oxidative stress in neurodegenerative diseases. Mol Neurobiol. 2016;53:4094–125.
Liu Z, Ren Z, Zhang J, Chuang CC, Kandaswamy E, Zhou T, et al. Role of ROS and nutritional antioxidants in human diseases. Front Physiol. 2018;9:477.
Wei C, Sun Y, Chen N, Chen S, Xiu M, Zhang X. Interaction of oxidative stress and BDNF on executive dysfunction in patients with chronic schizophrenia. Psychoneuroendocrinology. 2020;111:104473.
Forlenza MJ, Miller GE. Increased serum levels of 8-hydroxy-2′-deoxyguanosine in clinical depression. Psychosom Med. 2006;68:1–7.
Yoshihara K, Hiramoto T, Sudo N, Kubo C. Profile of mood states and stress-related biochemical indices in long-term yoga practitioners. Biopsychosoc Med. 2011;5:6.
Quesnel H, Père MC, Louveau I, Lefaucheur L, Perruchot MH, Prunier A, et al. Sow environment during gestation: part II. Influence on piglet physiology and tissue maturity at birth. Animal. 2019;13:1440–7.
Sahoo A, Paul RK, Thirumurgan P, Sharma S, Kumawat PK, De K. Immunological and plasma antioxidant response following protection of newborn lambs from cold by umbrella-type housing and lamb-jacket in winter. Biol Rhythm Res. 2019;52:726–33.
Gatellier P, Mercier Y, Renerre M. Effect of diet finishing mode (pasture or mixed diet) on antioxidant status of Charolais bovine meat. Meat Sci. 2004;67:385–94.
Rubio CP, Contreras-Aguilar MD, Quiles A, López-Arjona M, Cerón JJ, Martínez-Subiela S, et al. Biomarkers of oxidative stress in saliva of sheep: analytical performance and changes after an experimentally induced stress. Res Vet Sci. 2019;123:71–6.
Apak R. Current issues in antioxidant measurement. J Agric Food Chem. 2019;67:9187–202.
McBean GJ, Aslan M, Griffiths HR, Torrão RC. Thiol redox homeostasis in neurodegenerative disease. Redox Biol. 2015;5:186–94.
Klimiuk A, Maciejczyk M, Choromańska M, Fejfer K, Waszkiewicz N, Zalewska A. Salivary redox biomarkers in different stages of dementia severity. J Clin Med. 2019;8:840.
Lim ZX, Duong MN, Boyatzis AE, Golden E, Vrielink A, Fournier PA, et al. Oxidation of cysteine 34 of plasma albumin as a biomarker of oxidative stress. Free Radic Res. 2020;54:91–103.
Al-Mshhdani B, Terrill J, Grounds M, Arthur P. Plasma albumin thiol oxidation as a biomarker of muscle damage and inflammation. Neuromuscul Disord. 2019;29:S157–8.
Woolley LD, Pilmer LW, Stephens FJ, Lim ZX, Arthur PG, GholipourKanani H, et al. The effect of hydrogen peroxide concentration and water temperature on yellowtail kingfish Seriola lalandi in a repeated bathing treatment. Aquaculture. 2022;560:738545.
Grinman E, Espadas I, Puthanveettil SV. Emerging roles for long noncoding RNAs in learning, memory and associated disorders. Neurobiol Learn Mem. 2019;163:107034.
Wang J, Liu Y, Xia Q, Xia Q, Wang B, Yang C, et al. Potential roles of telomeres and telomerase in neurodegenerative diseases. Int J Biol Macromol. 2020;163:1060–78.
Zhan Y, Clements MS, Roberts RO, Vassilaki M, Druliner BR, Boardman LA, et al. Association of telomere length with general cognitive trajectories: a meta-analysis of four prospective cohort studies. Neurobiol Aging. 2018;69:111–6.
Codocedo JF, Inestrosa NC. Environmental control of microRNAs in the nervous system: Implications in plasticity and behavior. Neurosci Biobehav Rev. 2016;60(121–38):121–38.
Lee GS, Conine CC. The transmission of intergenerational epigenetic information by sperm microRNAs. Epigenomes. 2022;6:12.
Narayanan R, Schratt G. MiRNA regulation of social and anxiety-related behaviour. Cell Mol Life Sci. 2020;77:4347–64.
Issler O, Haramati S, Paul ED, Maeno H, Navon I, Zwang R, et al. MicroRNA 135 is essential for chronic stress resiliency, antidepressant efficacy, and intact serotonergic activity. Neuron. 2014;83:344–60.
Haramati S, Navon I, Issler O, Ezra-Nevo G, Gil S, Zwang R, et al. MicroRNA as repressors of stress-induced anxiety: the case of amygdalar miR-34. J Neurosci. 2011;31:14191–203.
Baudry A, Mouillet-Richard S, Schneider B, Launay JM, Kellermann O. MiR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants. Science. 2010;329:1537–41.
Tavares GA, Torres A, de Souza JA. Early life stress and the onset of obesity: proof of microRNAs’ involvement through modulation of serotonin and dopamine systems’ homeostasis. Front Physiol. 2020;11:925.
Roy B, Ochi S, Dwivedi Y. Potential of circulating miRNAs as molecular markers in mood disorders and associated suicidal behavior. Int J Mol Sci. 2023;24:4664.
Kozomara A, Birgaoanu M, Griffiths-Jones S. MiRBase: from microRNA sequences to function. Nucleic Acids Res. 2019;47:155–62.
Raza SHA, Wijayanti D, Pant SD, Abdelnour SA, Hashem NM, Amin A, et al. Exploring the physiological roles of circular RNAs in livestock animals. Res Vet Sci. 2022;152:726–35.
Miretti S, Lecchi C, Ceciliani F, Baratta M. MicroRNAs as biomarkers for animal health and welfare in livestock. Front Vet Sci. 2020;7:578193.
Kos MZ, Puppala S, Cruz D, Neary JL, Kumar A, Dalan E, et al. Blood-based miRNA biomarkers as correlates of brain-based miRNA expression. Front Mol Neurosci. 2022;15:817290.
Wiegand C, Savelsbergh A, Heusser P. MicroRNAs in psychological stress reactions and their use as stress-associated biomarkers, especially in human saliva. Biomed Hub. 2017;2:1–15.
Wang N, Zhang J, Xiao B, Sun X, Xie R, Chen A. Recent advances in the rapid detection of microRNA with lateral flow assays. Biosens Bioelectron. 2022;211:114345.
Bond CS, Fox AH. Paraspeckles: nuclear bodies built on long noncoding RNA. J Cell Biol. 2009;186:637–44.
Fox AH, Nakagawa S, Hirose T, Bond CS. Paraspeckles: where long noncoding RNA meets phase separation. Trends Biochem Sci. 2018;43:124–35.
Chujo T, Hirose T. Nuclear bodies built on architectural long noncoding RNAs: unifying principles of their construction and function. Mol Cells. 2017;40:889–96.
An H, Williams NG, Shelkovnikova TA. NEAT1 and paraspeckles in neurodegenerative diseases: a missing lnc found? Noncoding RNA Res. 2018;3:243–52.
Wang Y, Hu SB, Wang MR, Yao RW, Wu D, Yang L, et al. Genome-wide screening of NEAT1 regulators reveals cross-regulation between paraspeckles and mitochondria. Nat Cell Biol. 2018;20:1145–58.
Barry G, Briggs JA, Hwang DW, Nayler SP, Fortuna PRJ, Jonkhout N, et al. The long non-coding RNA NEAT1 is responsive to neuronal activity and is associated with hyperexcitability states. Sci Rep. 2017;7:40127.
Kukharsky MS, Ninkina NN, An H, Telezhkin V, Wei W, de Meritens CR, et al. Long non-coding RNA Neat1 regulates adaptive behavioural response to stress in mice. Transl Psychiatry. 2020;10:1–19.
Boros FA, Maszlag-Török R, Vécsei L, Klivényi P. Increased level of NEAT1 long non-coding RNA is detectable in peripheral blood cells of patients with Parkinson’s disease. Brain Res. 2020;1730:146672.
Simchovitz A, Hanan M, Niederhoffer N, Madrer N, Yayon N, Bennett ER, et al. NEAT1 is overexpressed in Parkinson’s disease substantia nigra and confers drug-inducible neuroprotection from oxidative stress. FASEB J. 2019;33:11223–34.
Bu F, Wang A, Zhu Y, You H, Zhang Y, Meng X, et al. LncRNA NEAT1: shedding light on mechanisms and opportunities in liver diseases. Liver Int. 2020;40:2612–26.
Dong P, Xiong Y, Yue J, Hanley SJB, Kobayashi N, Todo Y, et al. Long Non-coding RNA NEAT1: a novel target for diagnosis and therapy in human tumors. Front Genet. 2018;9:471.
Varki A. Biological roles of glycans. Glycobiology. 2017;27:3–49.
Flynn RA, Pedram K, Malaker SA, Batista PJ, Smith BAH, Johnson AG, et al. Small RNAs are modified with N-glycans and displayed on the surface of living cells. Cell. 2021;184:3109–24.
Disney MD. A glimpse at the glycoRNA world. Cell. 2021;184:3080–1.
Flynn R, Smith B, Johnson A, Pedram K, George B, Malaker S, et al. Mammalian Y RNAs are modified at discrete guanosine residues with N-glycans. bioRxiv. 2019;787614:1–30.
Kowalski MP, Krude T. Functional roles of non-coding Y RNAs. Int J Biochem Cell Biol. 2015;66:20–9.
Lünemann JD, von Gunten S, Neumann H. Targeting sialylation to treat central nervous system diseases. Trends Pharmacol Sci. 2021;42:998–1008.
Blackburn EH. Structure and function of telomeres. Nature. 1991;350:569–73.
Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB. Telomere end-replication problem and cell aging. J Mol Biol. 1992;225:951–60.
Reichert S, Criscuolo F, Verinaud E, Zahn S, Massemin S. Telomere length correlations among somatic tissues in adult zebra finches. PLoS ONE. 2013;8:e81496.
Bateson M, Poirier C. Can biomarkers of biological age be used to assess cumulative lifetime experience? Anim Welf. 2019;28:41–56.
Oliveira BS, Zunzunegui MV, Quinlan J, Fahmi H, Tu MT, Guerra RO. Systematic review of the association between chronic social stress and telomere length: a life course perspective. Ageing Res Rev. 2016;26:37–52.
Rentscher KE, Carroll JE, Mitchell C. Psychosocial stressors and telomere length: a current review of the science. Annu Rev Public Health. 2020;41:223–45.
Koliada AK, Krasnenkov DS, Vaiserman AM. Telomeric aging: mitotic clock or stress indicator? Front Genet. 2015;5:82.
Denham J. Telomere regulation: lessons learnt from mice and men, potential opportunities in horses. Anim Genet. 2020;51:3–13.
Uchino BN, Cawthon RM, Smith TW, Light KC, McKenzie J, Carlisle M, et al. Social relationships and health: is feeling positive, negative, or both (ambivalent) about your social ties related to telomeres? Health Psychol. 2012;31:789–96.
Lin X, Zhou J, Dong B. Effect of different levels of exercise on telomere length: A systematic review and meta-analysis. J Rehabil Med. 2019;51:473–8.
Schutte NS, Palanisamy SKA, McFarlane JR. The relationship between positive psychological characteristics and longer telomeres. Psychol Health. 2016;31:1466–80.
Schneper LM, Brooks-Gunn J, Notterman DA, Suomi SJ. Early-life experiences and telomere length in adult rhesus monkeys: an exploratory study. Psychosom Med. 2016;78:1066–71.
Bateson M. Cumulative stress in research animals: telomere attrition as a biomarker in a welfare context? BioEssays. 2016;38:201–12.
Pepper GV, Bateson M, Nettle D. Telomeres as integrative markers of exposure to stress and adversity: a systematic review and meta-analysis. R Soc Open Sci. 2018;5: 180744.
Badmus KA, Idrus Z, Meng GY, Mamat-Hamidi K. Telomere length, apoptotic, and inflammatory genes: novel biomarkers of gastrointestinal tract pathology and meat quality traits in chickens under chronic stress (Gallus gallus domesticus). Animals. 2021;11:3276.
Lai TP, Wright WE, Shay JW. Comparison of telomere length measurement methods. Proc R Soc B Biol Sci. 2018;373:20160451.
Refinetti R. Circadian rhythmicity of body temperature and metabolism. Temperature. 2020;7:321–62.
Brown SA, Zumbrunn G, Fleury-Olela F, Preitner N, Schibler U. Rhythms of mammalian body temperature can sustain peripheral circadian clocks. Curr Biol. 2002;12:1574–83.
Refinetti R. The circadian rhythm of body temperature. Front Biosci. 2010;15:564–94.
Maloney SK, Goh G, Fuller A, Vesterdorf K, Blache D. Amplitude of the circadian rhythm of temperature in homeotherms. CAB Reviews. 2019;14:1–30.
Refinetti R, Piccione G. Intra- and inter-individual variability in the circadian rhythm of body temperature of rats, squirrels, dogs, and horses. J Therm Biol. 2005;30:139–46.
Palacios C, Plaza J, Abecia JA. A high cattle-grazing density alters circadian rhythmicity of temperature, heart rate, and activity as measured by implantable bio-loggers. Front Physiol. 2021;12:707222.
Lamont EW, Legault-Coutu D, Cermakian N, Boivin DB. The role of circadian clock genes in mental disorders. Dialogues Clin Neurosci. 2007;9:333–42.
Elmore SK, Dahl K, Avery DH, Savage MV, Brengelmann GL. Body temperature and diurnal type in women with seasonal affective disorder. Health Care Women Int. 1993;14:17–26.
Souetre E, Salvati E, Wehr TA, Sack DA, Krebs B, Darcourt G. Twenty-four-hour profiles of body temperature and plasma TSH in bipolar patients during depression and during remission and in normal control subjects. Am J Psychiatry. 1988;145:1133–7.
Volicer L, Harper DG, Manning BC, Goldstein R, Satlin A. Sundowning and circadian rhythms in Alzheimer’s disease. A J Psychiatry. 2001;158:704–11.
Nikitopoulou G, Crammer JL. Change in diurnal temperature rhythm in manic-depressive illness. BMJ. 1976;1:1311–4.
Mota-Rojas D, Miranda-Cortés A, Casas-Alvarado A, Mora-Medina P, Boscato-Funes L, Hernández-Ávalos I. Neurobiology and modulation of stress-induced hyperthermia and fever in animal. Abanico veterinario. 2021;11:1–17.
Oka T. Stress-induced hyperthermia and hypothermia. Handb Clin Neurol. 2018;157:599–621.
Blache D, Maloney SK. New physiological measures of the biological cost of responding to challenges. In: Ferguson DM, Lee C, Fisher F, editors. Advances in Sheep Welfare. Sawston: Woodhead Publishing; 2017. p. 73–104.
Meyer LCR, Fick L, Matthee A, Mitchell D, Fuller A. Hyperthermia in captured impala (Aepyceros melampus): a fright not flight response. J Wildl Dis. 2008;44:404–16.
Pedernera-Romano C, Ruiz de la Torre J, Badiella L, Manteca X. ssociations between open-field behavior and stress-induced hyperthermia in two breeds of shee. Anim Welf. 2011;20:339–46.
Dallmann R, Steinlechner S, von Hörsten S, Karl T. Stress-induced hyperthermia in the rat: comparison of classical and novel recording methods. Lab Anim. 2006;40:186–93.
Sanger ME, Doyle RE, Hinch GN, Lee C. Sheep exhibit a positive judgement bias and stress-induced hyperthermia following shearing. Appl Anim Behav Sci. 2011;131:94–103.
Lees AM, Salvin HE, Colditz IG, Lee C. The influence of temperament on body temperature response to handling in angus cattle. Animals. 2020;10:172.
Adriaan Bouwknecht J, Olivier B, Paylor RE. The stress-induced hyperthermia paradigm as a physiological animal model for anxiety: a review of pharmacological and genetic studies in the mouse. Neurosci Biobehav Rev. 2007;31:41–59.
Watanabe S. Social factors modulate restraint stress induced hyperthermia in mice. Brain Res. 2015;1624:134–9.
Keeney AJ, Hogg S, Marsden CA. Alterations in core body temperature, locomotor activity, and corticosterone following acute and repeated social defeat of male NMRI mice. Physiol Behav. 2001;74:177–84.
Travain T, Valsecchi P. Infrared thermography in the study of animals’ emotional responses: a critical review. Animals. 2021;11:2510.
Barbini B, Benedetti F, Colombo C, Guglielmo E, Campori E, Smeraldi E. Perceived mood and skin body temperature rhythm in depression. Eur Arch Psychiatry Clin Neurosci. 1998;248:157–60.
Rushen J. Changing concepts of farm animal welfare: bridging the gap between applied and basic research. Appl Anim Behav Sci. 2003;81:199–214.
Richter SH, Hintze S. From the individual to the population – and back again? emphasising the role of the individual in animal welfare science. Appl Anim Behav Sci. 2019;212:1–8.
Morgan L, Raz T. Providing meaningful environmental enrichment and measuring saliva cortisol in pigs housed on slatted flooring. J Vis Exp. 2019;151: e60070.
Heimbürge S, Kanitz E, Tuchscherer A, Otten W. Is it getting in the hair? – cortisol concentrations in native, regrown and segmented hairs of cattle and pigs after repeated ACTH administrations. Gen Comp Endocrinol. 2020;295:113534.
Weaver SJ, Hynd PI, Ralph CR, Hocking Edwards JE, Burnard CL, Narayan E, et al. Chronic elevation of plasma cortisol causes differential expression of predominating glucocorticoid in plasma, saliva, fecal, and wool matrices in sheep. Domest Anim Endocrinol. 2021;74:106503.
Cheong Y, Oh C, Lee K, Cho KH. Survey of porcine respiratory disease complex-associated pathogens among commercial pig farms in Korea via oral fluid method. J Vet Sci. 2017;18:283–9.
Fels M, Rauterberg S, Schwennen C, Ligges U, Herbrandt S, Kemper N, et al. Cortisol/dehydroepiandrosterone ratio in saliva: endocrine biomarker for chronic stress in pigs? Livest Sci. 2019;222:21–4.
Nakagawa Y, To M, Saruta J, Yamamoto Y, Yamamoto T, Shimizu T, et al. Effect of social isolation stress on saliva BDNF in rat. J Oral Sci. 2019;61:516–20.
Heimbürge S, Kanitz E, Otten W. The use of hair cortisol for the assessment of stress in animals. Gen Comp Endocrinol. 2019;270:10–7.
Kovács L, Jurkovich V, Bakony M, Szenci O, Póti P, Tå’Zsér J. Welfare implication of measuring heart rate and heart rate variability in dairy cattle: literature review and conclusions for future research. Animal. 2014;8:316–30.
Camerlink I, Coulange E, Farish M, Baxter EM, Turner SP. Facial expression as a potential measure of both intent and emotion. Sci Rep. 2018;8:17602.
Seidl R. A functional-dynamic reflection on participatory processes in modeling projects. Ambio. 2015;44:750–65.
Nowotny H. Democratising expertise and socially robust knowledge. Sci Public Policy. 2003;30:151–6.
Fiorino D. Citizen participation and environmental risk: a survey of institutional mechanisms. Sci Technol Human Values. 1990;15:226–43.
Stauffacher M, Flüeler T, Krütli P, Scholz RW. Analytic and dynamic approach to collaboration: a transdisciplinary case study on sustainable landscape development in a swiss prealpine region. Syst Pract Action Res. 2008;21:409–22.
Fröhlich H, Balling R, Beerenwinkel N, Kohlbacher O, Kumar S, Lengauer T, et al. From hype to reality: data science enabling personalized medicine. BMC Med. 2018;16:1–15.
Fernandes JN, Hemsworth PH, Coleman GJ, Tilbrook AJ. Costs and benefits of improving farm animal welfare. Agriculture. 2021;11(2):104.
Acknowledgements
Not applicable.
Funding
This research was supported by Meat and Livestock Australia grant P.PSH.1232, the Australasian Pork Research Institute Ltd grant 5A-113, The University of Queensland and The University of Western Australia.
Author information
Authors and Affiliations
Contributions
All authors contributed equally to the development of the concept of the review. SB, JNF, DC, LD, SZ, and EAK searched the literature and produced the first draft. AHF, TMC, TJM, AJT, SKM, and DB edited the draft and produced the final version. All authors contributed equally to the multiple revisions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
None of the authors have a conflict of interest.
Glossary
- Animal welfare
-
The transient state within an animal that relates to what the animal experiences, and mental state is the experience of an animal influenced by internal and external factors [270].
- Animal experience or experiential state
-
Central processes integrate the perception of the environment with internal signals from bodily systems and cognitive inputs to generate a subjective state that includes, but is not limited to, sensations and emotional experiences. Animal experience changes according to changes in environmental and internal conditions. The quality of the experiential state ranges along a continuum from negative to positive experience. Experience varies between individuals according to their genetics, their history, and their perception of environmental cues.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Babington, S., Tilbrook, A.J., Maloney, S.K. et al. Finding biomarkers of experience in animals. J Animal Sci Biotechnol 15, 28 (2024). https://doi.org/10.1186/s40104-023-00989-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s40104-023-00989-z